Skip to main content
Premium Trial:

Request an Annual Quote

Anatrace Acquires Molecular Dimensions

NEW YORK (GenomeWeb) – Anatrace, a developer of high-purity detergents and synthetic lipids for use in membrane protein research, has acquired Molecular Dimensions, a structural biology research consumables and instrumentation supplier.

"We are pleased to add Molecular Dimensions to the Anatrace family as it establishes the European presence for the group and further solidifies its position in the structural biology arena," Brian Wall, founder and CEO of investment firm StoneCalibre, said in a statement. Anatrace is a StoneCalibre portfolio company. "We will continue to look for additional strategic acquisitions in the life science tools and diagnostics industry that could enhance the geographic presence, bolster the product and service offering, and complement the organic growth of the companies," Wall added.

Molecular Dimensions was founded in 1998, and serves universities, research institutes, and companies focused on drug discovery operating in Europe, the Americas, and Asia.

By adding Molecular Dimensions' products to its menu, Anatrace will be able to "offer a more complete portfolio of tools that aid and support drug discovery, disease prevention, and cure," said Anatrace CEO Ben Travis.

Specific details of the transaction were not disclosed.

StoneCalibre acquired Anatrace from Affymetrix in October 2013. Anatrace acquired structural biology tools developer Microlytic in January 2015.